Skip to content
Biodatica
Start free

FUNCTION THERAPEUTICS, INC.

MILWAUKEE, WI

Oncologysmall moleculeGrant-only
Compare Sign in to watch

What changed

NIH R43 · $0.0M · Small Molecule PAR1 Ligands for the Treatment of MASH

10mo agoGrant renewalSep 11, 2025Source filing (opens the source filing in a new tab)

Momentum

44no change

Momentum 44 out of 100, unchanged since the last recompute.

Some recent activity, at a steady rate.

Runway (estimate)

—unknown

No disclosed raise on file, so there is nothing to model from.

Stage

Grant-only

The furthest-along thing in the public record. Not a projection.

Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.

Peer position

12,474 pre-ticker oncology companies at Grant-only

Peer ranking — where this company sits among its stage-and-area peers by momentum, and how its runway compares to the peer median — is part of the Analyst tier.

Compare seats

A ranking of the same momentum figure the feed publishes, computed live against public-filing peers. It is a relative position, not a recommendation, and it is identical for every viewer.

Grant to raise

Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.

  1. Grant

    R43 · $500k · non-dilutive

    Sep 11, 2025

    FUNCTION THERAPEUTICS, INC. · PI DOCKENDORFF, CHRISTOPHER · NINDS · award ends Aug 31, 2027 · Parmodulins without Abuse Potential for the Treatment of Neuropathic Pain

    NIH RePORTER · NIH RePORTER 11183315 (opens the source filing in a new tab)

  2. Grant

    R43 · $40k · non-dilutive

    Aug 15, 2024

    FUNCTION THERAPEUTICS, INC. · PI DOCKENDORFF, CHRISTOPHER · NIDDK · award ends Jul 31, 2026 · Small Molecule PAR1 Ligands for the Treatment of MASH

    NIH RePORTER · NIH RePORTER 11163456 (opens the source filing in a new tab)

  3. Grant

    R43 · $89k · non-dilutive

    May 15, 2024

    FUNCTION THERAPEUTICS, INC. · PI DOCKENDORFF, CHRISTOPHER · NIDDK · award ends Apr 30, 2027 · Inhibitors of Thromboinflammation for Acute Kidney Injury

    NIH RePORTER · NIH RePORTER 11087659 (opens the source filing in a new tab)

Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources